Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial With High-Resolution Vessel-Wall MRI and Clinical Endpoints

NCT07586540 is registered in ClinicalTrials.gov with Middle East North Africa Stroke and Interventional Neurotherapies Organization as lead sponsor.

NCT NCT07586540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial With High-Resolution Vessel-Wall MRI and Clinical Endpoints
Lead sponsor
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 31, 2027
Completion date
September 30, 2030
Enrollment
280 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

carotid stenosis